Surgical Innovations Share Discussion Threads

[buywell2] 06/4/2021 23:09

POST REMOVED.

[jmf69] 30/3/2021 10:49

Q11: For the sustainability initiatives, for example the 3x uni hospitals converted - how much does a hospital conversation mean in terms of revenue and profitability?

[jmf69] 30/3/2021 10:41

There was a question in the investor presentation about how much revenue for each of the 3 hospitals currently converted in the UK. The answer was obviously depending on which instruments they take but for a typical lap cholecystectomy would be about 1000 procedures annually with each lap cholecystectomy kit costing £100. The answer was given as £10k plus other items added in leading to £25k to £30k.For anyone with a gcse in maths 100 × 1000 =100000 = 100k.So each hospital would be 100k for the lap cholecystectomy kits over the year and not 10k as answered. I was just listening to the q&a section again. Gla.

[jmf69] 27/3/2021 19:20

Presentation and Q&A now available to view.If the vaccine rollout continues at pace and is effective then I believe we are in for a good year. Gla.

[xylemflow] 26/3/2021 08:35

Buywell, thank you for your long and informative post. Very interesting. There is no doubt that green issues are insanely topical at the moment and for the fireable future they will only become more important. I agree with your conclusion. All SUN needs now are some patients!

[buywell3] 26/3/2021 00:44

IMO Re what is referred to in the results as being 'sustainability' ie environment friendly and conducive to plastic waste reduction / CO2 reduction / Global Warming issues that now are affecting planet Earth.

Surgical Innovations market an increasing range of Resposable™ products :
Which are marketed by both Surgical Innovations and their 100% owned subsidiary Elemental Healthcare (EH) which SUN acquired around 2 years ago


In a Laparoscopic Cholecystectomy, a typical fully disposable kit used in many hospitals all over the world weighs 713g.

But Elemental Healthcare (100% owned by SUN) market a Surgical Innovations kit comprising of Resposable™ instruments made by Surgical Innovations and EH clients which weighs only 82g, a difference of 631g or put another way a 83% saving in throw away plastic much of which gets burned or goes to landfill.



===== Resposable™ products reduce plastic waste in Operating Theatres by 83%* =====

So if the EH/SUN range of Resposable™ Surgical Instruments were to be used then performing Laparoscopic / Keyhole / Minimally Invasive Surgery (MIS) would result in the rather staggering stat that :

The equivalent of 52 plastic bottles, per surgery could be eliminated from incineration which would represent 631g of plastic in just one Laparoscopic Cholecystectomy operation .

Increasingly large volumes of clinical waste are being incinerated by hospitals each year, a large percentage of this waste is from plastic materials. Hospitals are constantly under pressure to achieve cost savings and make improvements.

The innovative design of Surgical Innovations Resposable™ product ranges provide a high quality reusable instrument with the clinical benefits of a small disposable element. Providing the solution for Hospitals looking to reduce costs and waste whilst maintaining reliability and quality.

Disposing of a small item dramatically reduces the volume of waste and cost of disposal for the Hospital. The recurring cost of the small disposable element is also much less than a fully disposable device, providing two cost saving benefits.

*We have produced a white paper which considers the role of fully disposable plastic instruments and the considerable issue of plastic waste in the Operating Theatre and examines the benefits of Resposable™ medical devices as an alternative.

We also examine the consequential CO2 emissions of Operating Theatre waste management to provide a comparison aiding key decision-makers in the NHS and private healthcare.

A few points of interest:

« The NHS in England is responsible for around 20 million tonnes of Carbon Dioxide emissions annually and spends more than £50 million on Carbon Permits every year. (1)

« Although Operating Theatres physically occupy a relatively small area in hospitals, they generate a disproportionate amount of waste. In the US, it is estimated that 20%-33% of all hospital waste is generated by the operating theatres and a single operation can generate more waste than a family of four produces in one week. (2,3)

« Carbon Dioxide emissions attributable to the NHS are greater than all of the aircraft departing from London’s Heathrow Airport. (1)

Conclusion:

Management of waste in the Operating Theatre is a multifactorial task which should be managed around the 4 R’s (Reduce, Reuse, Recycle – Resposable™). Many of the solutions are simple – the provision of recycling bins in the OR suite so that cardboard packaging and paper IFU’s can be recycled easily. Others are much more difficult – reducing the amount of plastic waste in many operations requires a root-and-branch rethink by product manufacturers to dramatically reduce the amount of packaging and the volume of plastic used in instrumentation.

In our example of the Laparoscopic Cholecystectomy, a typical fully disposable kit used in many hospitals all over the world weighs 713g. A kit comprising Resposable™ instruments weighs 82g. A difference of 631g.

There are over 70,000 Cholecystectomies performed in the UK every year. If every case was converted to using Resposable™ instruments, this would represent a reduction of over 44,000kg of plastic waste per year.

If a surgical instrument is equally effective, costs less than what is currently used and has the crucial benefit of dramatically reducing the CO2 footprint, then we are urging our NHS Hospitals to prioritise the consideration of this change.
*Contact our UK subsidiary, Elemental Healthcare Ltd to read the full white paper and find out how to begin to reduce plastic waste in operating theatres by 83%.


buywell adds :

The NHS and other Heath Services in many countries have signed up to reduce their plastic waste

It could be said imo that the SUN Resposable™ Trademarked brand and other Reposable Surgical Laparoscopic Instruments (Microline ) marketed to the NHS by Elemental Healthcare (EH) are at present in a 'SWEET SPOT' in that:

A) Reposable products do the job just as well or better than disposable products

B) A Reposable product made by SUN or sold by EH will save clients money per laparoscopic operation over its useful lifetime when compared to the cost of XXX numbers of disposable instruments used.

C) Reposable products save on waste plastics and the costs of their disposal

D) Reposable products help meet Government set plastic/CO2 reduction targets


This is why there are a growing number of NHS Trusts switching from Disposable to Resposable™ products --- they easily solve a multitude of problems AND save monies as well.



A VERY shrewd and well thought initiative by our new SUN CEO and COO from the Elemental Healthcare acquisition -- that will now imo pay off handsomely as the world has to go green.

dyor

[jmf69] 25/3/2021 15:06

I thought it was a very useful and informative investor meeting. Happy to hold for now with things looking up particularly with increasing access to the USA market.

[jmf69] 25/3/2021 09:14

https://www.investormeetcompany.com/surgical-innovations-group-plc/register-investor

[gnnmartin] 25/3/2021 09:13

I did not know there is to be an investor presentation, can you give details, please? I can't find it in the results RNS.

[abeygale] 25/3/2021 09:03

The chart says 3p plus. Therefore I am expecting SUN to turn from red to blue today.

[jmf69] 25/3/2021 08:54

Agreed. Results seem ok given the covid-19 impact. We knew revenue was going to be down and importantly the current year is ahead 11% compared to last year before covid-19 hit major markets.Topped up 200k this morning and given the vaccine rollout and return of elective surgery, we should see a major recovery this year. Not to mention the new contracts in the USA. Anyone attending the investor presentation this afternoon?

[xylemflow] 25/3/2021 08:49

I actually thought this set of results was much less bad than expected. There is a lot to look forward to when hospitals eventually start treating patients. My guess is that share price will bounce back quickly.

[kenone] 25/3/2021 08:05

Actually we need PATIENTS well as PATIENCE

[kenone] 25/3/2021 08:01

Results for last year were always going to be poor due to COVID. Future looks good. Patience is needed !

[buywell3] 25/3/2021 07:46

============ SUN Results as expected --- 2021 the recovery starts =============


From the Finals

Chairman Nigel Rogers :

"Since the beginning of 2021, we have completed several key partnership agreements to expand our reach in the US market and secure a broader range of products for UK distribution. We have also made continued progress in developing the sustainability message, and in product development, where we expect to extend the SI branded range through the launch of a number of new products in the second half of the year.



"Accordingly, having demonstrated strength and resilience throughout 2020, the Group is now ideally positioned to build exciting growth as markets continue to recover."

Our "sustainability in surgery" messaging continues to resonate in key markets post Covid-19, none more so than the UK with the NHS and governing medical bodies endorsing the drive for a more sustainable healthcare system. During the break in elective surgery, the Elemental team has been working closely with a number of large NHS Trusts to plan product evaluations based on the reduction of plastic waste. The evaluation process recommenced in August 2020, following the first lockdown, and has continued to be rolled out to a number of hospitals in at least five large NHS Trusts.

Clearly the second wave has impacted the speed of the evaluations, but to date the outlook remains promising. Assuming these evaluations conclude positively, transition to the relevant product ranges is expected to take place during the first half of 2021.

The Green Surgery Challenge, an initiative between the Company, Centre for Sustainable Healthcare ('CSH'), and the Royal Colleges of Surgeons in both England and Scotland was launched in early 2021, providing a unique platform for our portfolio of resposable devices to deliver their sustainability credentials.

Additional sustainability-driven evaluations are ongoing with three major US general procurement organisations (GPOs), and the messaging is reaching an ever receptive audience around the globe.



buywell comments :

The decision to further adopt Reposable Surgical Instruments in regard to sustainability ie the need for a reduction in plastic waste seems imo to mean that many NHS Trusts in 2021 are going to change over to Surgical Innovations products -- likewise the USA and other parts of the world.

2021 should see a sunrise recovery imo

dyor

[buywell2] 24/3/2021 20:50

POST REMOVED

[buywell3] 24/3/2021 09:43

Something that not many yet talk about but is in fact the WHALE in the room namely
long term Covid



-------------------- NHS NEW 'LONG COVID' CLINICS ------------------




The NHS planned to open 40 'long COVID' CLINICS in November 2020 to treat a perceived 60 thousand patients/sufferers


15 November 2020


The NHS will launch a network of more than 40 ‘long COVID’ specialist clinics within weeks to help thousands of patients suffering debilitating effects of the virus months after being infected.

The clinics, due to start opening at the end of November, will bring together doctors, nurses, therapist and other NHS staff to physical and psychological assessments of those experiencing enduring symptoms.

The condition, which is thought to affect more than 60,000 people in the UK, can cause continuing fatigue, brain fog, breathlessness and pain.

buywell says --- to be fair everone is learning about long COVID on the job or put another way , we still don't know just how many organs and parts of the body Covid-19 affects. Every individual will in effect be left with various forms of long COVID depending upon the amount of viral load they took on when becoming infected and the variant strain.

So a multiplicity of symptoms and consequences for each person that catches Covid-19 , and 30% of who it is now thought, then suffer from long COVID

So the 60,000 number above became circa 300,000 plus in Jan 2021
htps://www.bbc.com/news/uk-england-oxfordshire-55668650
and medical experts and advisers are talking about 1M long COVID sufferers coming


long COVID is also hurting the staff , the nurses and doctors within the NHS as many of them are also becoming sufferes

So it would seem that the number of long COVID Clinics looks set to increase dramatically both in number , so as to cover the whole of the UK --- but also in size and presumably the range of services that they will have to offer different patients

Already that 40 long Covid clinic number is on the way to doubling and looks set to continue to double to meet long COVID demands.


'long COVID' also referred to as 'long haul COVID' in the USA and folks there hence being termed 'long haulers' America has the same problem as the UK and the EU as the UK Variant spreads becoming the world dominant strain in the next week.

The BMJ in the UK published a study recently titled :

Long covid: Damage to multiple organs presents in young, low risk patients

17 November 2020

The study enrolled participants at two UK sites in Oxford and London between April and August 2020. Two hundred and one individuals (mean age 44 (standard deviation 11.0) years) completed assessments after SARS-CoV-2 infection a median of 140 days after initial symptoms.

It was found that:

The most commonly reported ongoing symptoms—regardless of hospitalisation status—were fatigue (98%), muscle ache (88%), shortness of breath (87%), and headache (83%). There was evidence of mild organ impairment in the heart (32% of patients), lungs (33%), kidneys (12%), liver (10%), pancreas (17%), and spleen (6%).

Two thirds (66%) of participants had impairment in one or more organ systems and there was evidence of multiorgan impairment in a quarter (25%) of individuals, with varying degrees of overlap across multiple organs.

The above terrible outcomes (in buywells opine ) was obtained on the study where these 201 people :

prevalence of pre-existing conditions was low (obesity: 20%, hypertension: 6%, diabetes: 2%, heart disease: 4%), and less than a fifth (18%) of individuals had been hospitalised with covid-19.




So the cohort in the study where better than normal folks re UK obesity rates and heart disease and only 18% of them had been hospitalized.


buywell can see the need for HUNDREDS of long COVID clinics and the need for medical support/care/equipment at peoples homes for hundreds of thousands of people under the umbrella of newly created long COVID carers --- is imo a given

[buywell2] 23/3/2021 21:23

POST REMOVED

[bathroom12] 23/3/2021 20:09

Lol, thank you, I ha. E bought some when it was 1p and all the way to 8p
Still praying 😂😂

[xylemflow] 23/3/2021 19:12

Hi Shani, welcome to the thread of the eternally hopeful!

[bathroom12] 23/3/2021 18:25

I am Shani by the way, nice to e-meet you all